Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · IEX Real-Time Price · USD
11.64
+0.10 (0.87%)
At close: Apr 26, 2024, 4:00 PM
11.79
+0.15 (1.29%)
After-hours: Apr 26, 2024, 4:27 PM EDT
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $3.25 billion as of April 26, 2024. Its market cap has increased by 147.84% in one year.
Market Cap
3.25B
Enterprise Value
2.96B
1-Year Change
147.84%
Ranking
Category
Stock Price
$11.64
Market Cap Chart
Since October 15, 2010, Iovance Biotherapeutics's market cap has increased from $79.00M to $3.25B, an increase of 4,015.36%. That is a compound annual growth rate of 31.60%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 3.22B | -1.45% |
Apr 24, 2024 | 3.27B | -1.26% |
Apr 23, 2024 | 3.31B | 4.77% |
Apr 22, 2024 | 3.16B | 0.09% |
Apr 19, 2024 | 3.16B | -3.50% |
Apr 18, 2024 | 3.27B | -0.68% |
Apr 17, 2024 | 3.30B | -1.01% |
Apr 16, 2024 | 3.33B | 0.25% |
Apr 15, 2024 | 3.32B | -3.80% |
Apr 12, 2024 | 3.45B | -6.29% |
Apr 11, 2024 | 3.68B | 4.85% |
Apr 10, 2024 | 3.51B | -4.84% |
Apr 9, 2024 | 3.69B | 1.15% |
Apr 8, 2024 | 3.65B | -3.40% |
Apr 5, 2024 | 3.78B | -0.52% |
Apr 4, 2024 | 3.80B | -2.93% |
Apr 3, 2024 | 3.91B | 1.74% |
Apr 2, 2024 | 3.85B | -2.96% |
Apr 1, 2024 | 3.96B | -4.25% |
Mar 28, 2024 | 4.14B | 5.11% |
Mar 27, 2024 | 3.94B | 0.35% |
Mar 26, 2024 | 3.92B | -3.30% |
Mar 25, 2024 | 4.06B | -3.26% |
Mar 22, 2024 | 4.20B | -2.21% |
Mar 21, 2024 | 4.29B | 2.88% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
HUTCHMED (China) | 3.31B |
Crinetics Pharmaceuticals | 3.30B |
Evolent Health | 3.27B |
SpringWorks Therapeutics | 3.26B |
Fortrea Holdings | 3.25B |
10x Genomics | 3.22B |
Sotera Health Company | 3.20B |
Bausch Health Companies | 3.15B |